232.63 +0.01 (0.00%)
After hours: 4:02PM EDT
Previous Close | 234.97 |
Open | 234.03 |
Bid | 231.11 x 900 |
Ask | 231.85 x 800 |
Day's Range | 228.50 - 237.17 |
52 Week Range | 63.16 - 279.46 |
Volume | 82,995 |
Avg. Volume | 121,390 |
Market Cap | 2.736B |
Beta (5Y Monthly) | 1.50 |
PE Ratio (TTM) | 26.80 |
EPS (TTM) | 8.68 |
Earnings Date | May 03, 2021 - May 07, 2021 |
Forward Dividend & Yield | 5.68 (2.42%) |
Ex-Dividend Date | Mar 29, 2021 |
1y Target Est | 301.75 |
Philip Morris' (PM) first-quarter performance reflects gains from favorable pricing variance as well as growth in heated tobacco shipment volumes.
Medifast, Inc. (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2021 on Tuesday, May 4, 2021, after market close. The Company will host a conference call to discuss these results with additional comments and details. Participants from the Company will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
Medifast (MED) possesses solid growth attributes, which could help it handily outperform the market.